Evidence map›Paper›PMID 30157691›Full record

ReviewThe Journal of international medical research2018

Cognitive function in patients with coronary artery disease: A literature review.

J Burkauskas, P Lang, A Bunevičius, J Neverauskas, M Bučiūtė-Jankauskienė, N Mickuvienė

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in The Journal of international medical research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Disentangling the effects of sex and gender onAlzheimer's & dementia (Amsterdam, Netherlands)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

J Burkauskas1 Behavioral Medicine Institute, Lithuanian University of Health Sciences, Vydūno Str. 4/J. Šliūpo Str. 7, LT-00135, Palanga, Lithuania.ORCID https://orcid.org/0000-0002-3928-2151
P Lang2 Harvard Medical School, Laboratory of Clinical & Experimental Psychopathology, Dr. John C. Corrigan Mental Health Center, Harvard Medical School, 49 Hillside Street, Fall River, MA 02720, USA.
A Bunevičius3 Laboratory of Clinical Research, Neuroscience Institute, Lithuanian University of Health Sciences, Eivenių st. 4, LT-50161, Kaunas, Lithuania.
J Neverauskas1 Behavioral Medicine Institute, Lithuanian University of Health Sciences, Vydūno Str. 4/J. Šliūpo Str. 7, LT-00135, Palanga, Lithuania.
M Bučiūtė-Jankauskienė1 Behavioral Medicine Institute, Lithuanian University of Health Sciences, Vydūno Str. 4/J. Šliūpo Str. 7, LT-00135, Palanga, Lithuania.
N Mickuvienė1 Behavioral Medicine Institute, Lithuanian University of Health Sciences, Vydūno Str. 4/J. Šliūpo Str. 7, LT-00135, Palanga, Lithuania.
Lithuanian University of Health Sciences · LTHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective Cognitive function impairment is a well-documented complication of cerebrovascular disease (CBVD). Less is known about what factors affect the deterioration of cognitive function in patients with coronary artery disease (CAD). The aim of this review is to explore recent studies investigating factors associated with cognitive function in patients with CAD. Methods Studies published from 2010 to 2016 were identified through a systematic search of MEDLINE/PubMed and were included if they addressed factors affecting cognitive function in the CAD population. Results Of the 227 publications identified, 32 were selected for the review. Five factors tentatively affecting cognitive function in patients with CAD were identified: coronary artery bypass grafting (CABG) surgery, apolipoprotein E4 (APOE4) genotype, left ventricular ejection fraction (LVEF), medication use, and various hormones and biomarkers. Conclusion New techniques in CABG surgery have proven to alleviate postoperative cognitive decline. Researchers are still debating the effects of APOE4 genotype, LVEF, and the use of cardiovascular medications on cognitive function. Thyroid hormones and biomarkers are associated with cognitive function, but the exact nature of the association is debatable. Longitudinal studies should clarify those associations. In addition, cross-sectional studies addressing other causes of cognitive decline in patients with CAD are warranted.

Indexed as

Apolipoprotein E4CognitionCognition DisordersCoronary Artery BypassCoronary Artery DiseaseHumansStroke VolumeVentricular Dysfunction, LeftVentricular Function, LeftApolipoprotein E4APOE4 genotypebiomarkersCognitive functioncoronary artery bypass graftingcoronary artery diseaseleft ventricular ejection fractionmedication use

Identifiers

PMID30157691
PMCPMC6166352
OpenAlexW2888912790

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.